Abstract
A1079 - Epigenetic treatment with BET inhibitor PLX51107 sensitizes urothelial carcinoma cells to cisplatin and PARP inhibitors
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have